NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes

Stock Information for NanoVibronix Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About NanoVibronix Inc.

Successful Independent Study of the NanoVibronix UroShield® Device Published in the Australian and New Zealand Continence Journal
NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp.
NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan
NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement
NanoVibronix Provides Business Update
NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany
NanoVibronix Signs Letter of Intent with Potential New Distributor
NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.